Heska to earn spots in Russell indices; Putney launches generic version of Zoetis anesthetic; IFAH-Europe names Bayer exec as chairman;

> Heska ($HSKA) announced that it expects to be included in the Russell 3000 Index, Global Index, and small-cap Russell 2000 Index. Release

> Putney announced it is the first-to-market with a generic version of Zoetis' ($ZTS) Telazol (tiletamine HCl and zolazepam HCl), an injectable rapid-acting anesthetic for dogs and cats undergoing short veterinary procedures. Release

> The International Federation for Animal Health-Europe has appointed Christian Behm, head of the Europe region for Bayer Animal HealthCare, as its new chairman. Release

> Vets Plus announced it will distribute Neutricks, a line of products made by Quincy Bioscience to treat cognitive decline in aging dogs and cats. Release

> Boulder Dog Food Company is recalling some lots of its Chicken Sprinkles because of potential Salmonella contamination. Release

Suggested Articles

Pfizer spinoff Zoetis met Q2 expectations and brightened its full-year forecast, but it's looking to M&A to drive further growth.

Fresenius’ new CEO has pulled off a dealmaking double play, committing more than $5.4 billion to expand its reach in both sterile generics and in biosimilars.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…